Application
Western blot analysis of extracts from Hela cells untreated(lane 1) or treated with UV(lane 2) using CDK2(Phospho-Thr160)Application
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using CDK2 (Phospho-Thr160) Antibody (left) or the same antibody preincubated with blocking peptide (right).Application
Western blot analysis of extracts from Hela cells untreated (lane 1) or treated with UV (lane 2) using CDK2 (Phospho-Thr160) Antibody .| Product Name | CDK2 (phospho Thr160) antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to CDK2 (Phospho Thr160)Involved in the control of the cell cycle. Interacts with cyclins A, B1, B3, D, or E. Activity of CDK2 is maximal during S phase and G2. |
| Immunogen | Peptide sequence around phosphorylation site of threonine 160 (T-Y-T(p)-H-E) derived from Human CDK2. |
| Modification | p-Thr160 |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | IHC-PWB |
| Suggested starting dilutions are as follows. WB: 1:500~1:1000, IHC-P: 1:50~1:100. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | p33(CDK2) CDK2 cdc2-related protein kinase cell devision kinase 2 cyclin-dependent kinase 2 p33 protein kinase cell division protein kinase 2 |
|---|---|
| Target | CDK2 (Phospho Thr160) |
| Molecular Weight(MW) | 34 (note) |
Application
Western blot analysis of extracts from Hela cells untreated(lane 1) or treated with UV(lane 2) using CDK2(Phospho-Thr160)
Application
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using CDK2 (Phospho-Thr160) Antibody (left) or the same antibody preincubated with blocking peptide (right).
Application
Western blot analysis of extracts from Hela cells untreated (lane 1) or treated with UV (lane 2) using CDK2 (Phospho-Thr160) Antibody .| Application Notes | Suggested starting dilutions are as follows. WB: 1:500~1:1000, IHC-P: 1:50~1:100. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
